Research Profile

Janet O'Sullivan

Biography

Research Interests

Research interests focus on cancer research in PET including image processing, manipulation and analysis, and survival analysis.

Publications

Peer Reviewed Journals

 YearPublication
(2003)'A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data'
O'Sullivan F, Roy S, Eary J.: ; (2003) 'A statistical measure of tissue heterogeneity with application to 3D PET sarcoma data'. Biostatistics, 4 (3):433-448 [Details]
(2003)'Modelling multivariate biomechanical measurements of the spine during a rowing exercise'
O'Sullivan F, O'Sullivan J, Bull AM, McGregor AH. ; (2003) 'Modelling multivariate biomechanical measurements of the spine during a rowing exercise'. Clinical Biomechanics, 18 (6):488-493 [Details]
(2005)'Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET'
O'Sullivan F., Roy S., O'Sullivan J., Vernon C., and Eary JF. ; (2005) 'Incorporation of tumor shape into an assessment of spatial heterogeneity for human sarcomas imaged with FDG-PET'. Biostatistics, 6 (2):293-301 [Details]
(2002)'Factorial design considerations'
Green S, Liu PY, O’Sullivan J. (2002) 'Factorial design considerations'. Journal of Clinical Oncology, 20 [Details]
(2004)'Hypoxia and glucose metabolism in malignant tumors'
Rajendran, J.G. and Mankoff, D.A. and OÂ’Sullivan, F. and Peterson, L.M. and Schwartz, D.L. and Conrad, E.U. and Spence, A.M. and Muzi, M. and Farwell, D.G. and Krohn, K.A. (2004) 'Hypoxia and glucose metabolism in malignant tumors'. Clinical cancer research, 10 (7):2245-2252 [Details]
(2006)'Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer'
Rajendran, J.G. and Schwartz, D.L. and O'Sullivan, J. and Peterson, L.M. and Ng, P. and Scharnhorst, J. and Grierson, J.R. and Krohn, K.A. (2006) 'Tumor hypoxia imaging with [F-18] fluoromisonidazole positron emission tomography in head and neck cancer'. Clinical cancer research, 12 (18):5435-5441 [Details]
(2007)'Bayesian use of historical data to guide blood input function extraction from dynamic PET studies'
O'Sullivan, F. and Kirrane, J. and Muzi, M. and O'Sullivan, J. and Spence, A. and Krohn, K. (2007) 'Bayesian use of historical data to guide blood input function extraction from dynamic PET studies'. J Nucl Med, 48 (suppl 2) [Details]
(2009)'Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics'
Punt, S.E.W. and Eary, J.F. and OÂ’Sullivan, J. and Conrad, E.U. (2009) 'Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics'. Nuclear medicine communications, 30 (7) [Details]
(2009)'Risk assessment based on FDG-PET imaging in patients with synovial sarcoma'
Lisle, J.W. and Eary, J.F. and OÂ’Sullivan, J. and Conrad, E.U. (2009) 'Risk assessment based on FDG-PET imaging in patients with synovial sarcoma'. Clinical Orthopaedics and Related Research\textregistered, 467 (6):1605-1611 [Details]
(2011)'A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma'
O'Sullivan, F. and Wolsztynski, E. and O'Sullivan, J. and Richards, T. and Conrad, E. and Eary, J. (2011) 'A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma'. Medical Imaging, IEEE Transactions on, (99):1-1 [Details]
(1988)'Deconvolution of episodic hormone data: An analysis of the role of season on the onset of puberty in cows'
O'Sullivan, F. and O'Sullivan, J. (1988) 'Deconvolution of episodic hormone data: An analysis of the role of season on the onset of puberty in cows'. Biometrics, :339-353 [Details]
(1992)'Phase II trial of didemnin-B in advanced epithelial ovarian cancer'
Cain, J.M. and Liu, PY and Alberts, D.E. and Gallion, H.H. and Laufman, L. and O'Sullivan, J. and Weiss, G. and Bickers, J.N. (1992) 'Phase II trial of didemnin-B in advanced epithelial ovarian cancer'. Investigational new drugs, 10 (1):23-24 [Details]
(1992)'A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial'
Weiss, G.R. and Liu, PY and O'Sullivan, J. and Alberts, D.S. and Brown, T.D. and Neefe, J.R. and Hutchins, L.F. (1992) 'A randomized phase II trial of trimetrexate or didemnin B for the treatment of metastatic or recurrent squamous carcinoma of the uterine cervix: a Southwest Oncology Group trial'. Gynecologic oncology, 45 (3):303-306 [Details]
(1992)'Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study'
Albain, K.S. and Green, S. and LeBlanc, M. and Rivkin, S. and O'Sullivan, J. and Kent Osborne, C. (1992) 'Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study'. Breast cancer research and treatment, 22 (3):273-284 [Details]
(1995)'Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study'
Budd, G.T. and Green, S. and O'Bryan, R.M. and Martino, S. and Abeloff, M.D. and Rinehart, J.J. and Hahn, R. and Harris, J. and Tormey, D. and O'Sullivan, J. (1995) 'Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study'. Journal of clinical oncology, 13 (4) [Details]
(1996)'Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study'
Rivkin, S.E. and Green, S. and O'Sullivan, J. and Cruz, A.B. and Abeloff, M.D. and Jewell, W.R. and Costanzi, J.J. and Farrar, W.B. and Osborne, C.K. (1996) 'Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study'. Journal of clinical oncology, 14 (1):46-51 [Details]
(1996)'Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study'
Alberts, DS and Liu, PY and Hannigan, EV and O'Toole, R. and Williams, SD and Young, JA and Franklin, EW and Clarke-Pearson, DL and Malviya, VK and Dubeshter, B. and others (1996) 'Phase III study of intraperitoneal cisplatin-intravenous cyclophosphamide versus intravenous cisplatin-intravenous cyclophosphamide in patients with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG Intergroup study'. International Journal of Gynecological Cancer, 6 [Details]
(1997)'bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study'
Elledge, R.M. and Green, S. and Howes, L. and Clark, G.M. and Berardo, M. and Allred, D.C. and Pugh, R. and Ciocca, D. and Ravdin, P. and O'Sullivan, J. and others (1997) 'bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study'. Journal of clinical oncology, 15 (5):1916-1922 [Details]
(1998)'HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study'
Elledge, R.M. and Green, S. and Ciocca, D. and Pugh, R. and Allred, D.C. and Clark, G.M. and Hill, J. and Ravdin, P. and O'Sullivan, J. and Martino, S. and others (1998) 'HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study'. Clinical cancer research, 4 (1):7-12 [Details]
(2009)'Nonparametric residue analysis of dynamic PET data with application to cerebral fdg studies in normals'
O'Sullivan, F. and Muzi, M. and Spence, A.M. and Mankoff, D.M. and O'Sullivan, J.N. and Fitzgerald, N. and Newman, G.C. and Krohn, K.A. (2009) 'Nonparametric residue analysis of dynamic PET data with application to cerebral fdg studies in normals'. Journal of the American Statistical Association, 104 (486):556-571 [Details]
(2010)'Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function'
O'Sullivan, F. and Kirrane, J. and Muzi, M. and O'Sullivan, JN and Spence, AM and Mankoff, DA and Krohn, KA (2010) 'Kinetic quantitation of cerebral PET-FDG studies without concurrent blood sampling: statistical recovery of the arterial input function'. Medical Imaging, IEEE Transactions on, 29 (3):610-624 [Details]

Conference Publications

 YearPublication
(2003)Annual meeting of the Society of Nuclear Medicine
Rajendran J,O’Sullivan F, Peterson L,O’Sullivan J, Schwartz D,Muzi M, Grierson J, Krohn K (2003) Heterogeneity Measure of Tumor Hypoxia and Metabolism in Head and Neck Cancer: FMISO and FDG-PET as Molecular Probes Annual meeting of the Society of Nuclear Medicine [Details]
(2010)2010 IEEE Nuclear Science Symposium and Medical Imaging Conference
Collaboration, A. and Collaboration, AMS (2010) Contributions from Collaborations 2010 IEEE Nuclear Science Symposium and Medical Imaging Conference [Details]
(2010)Nuclear Science Symposium Conference Record (NSS/MIC), 2010 IEEE
Wolsztynski, E. and O'Sullivan, F. and Conrad, E.U. and O'Sullivan, J. and Eary, J.F. (2010) A novel approach to the assessment of response to chemotherapy in sarcoma imaged with PET-FDG Nuclear Science Symposium Conference Record (NSS/MIC), 2010 IEEE , pp.2957-2962 [Details]
(1995)Proc Am Soc Clin Oncol
Alberts, DS and Liu, PY and Hannigan, EV and O'Toole, R. and Williams, SD and Young, J. and Franklin, D. and Clarke-Pearson, VK and Malvyia, B. and DuBeshter, W. and others (1995) Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) VS IV CDDP/IV CPA in patients (PTS) with optimal disease stage III ovarian cancer: a SWOG-GOG-ECOG intergroup study (INT 0051) Proc Am Soc Clin Oncol [Details]
(1996)Proc Am Soc Clin Oncol
Geyer Jr, CE and Green, SJ and Moinpour, C. and O'Sullivan, J. and Goodwin, D. and Canfield, V. and others (1996) A phase II trial of paclitaxel in patients with metastatic refractory carcinoma of the breast: a Southwest Oncology Group (SWOG) study Proc Am Soc Clin Oncol [Details]
(1997)Proc Am Soc Clin Oncol
Albain, K. and Green, S. and Osborne, K. and Cobau, E. and Levine, J. and Ingle, J. and Pritchard, K. and Schneider, D. and OÂ’Sullivan, J. and Hess, E. and others (1997) Tamoxifen (T) versus cyclophosphamide, Adriamycin and 5-FU plus either concurrent or sequential T in postmenopausal, receptor (+), node (+) breast cancer: a Southwest Oncology Group phase III Intergroup trial (SWOG-8814, INT-0100) Proc Am Soc Clin Oncol [Details]

Contact details

Search profiles by name

Search profiles by topic

School of Biological, Earth and Environmental Sciences

An Scoil Eolaíochtaí Bitheolaíocha, Domhaneolaíocha agus Comhshaoil

University College Cork, Distillery Fields, North Mall, Cork, Ireland T23 N73K

Top